⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBP News
Corbus Pharmaceuticals Holdings, Inc.
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
globenewswire.com
CRBP
Choctaw Casinos & Resorts Expands Cashless Gaming Options, Through Partnership with EDGE Markets
globenewswire.com
CRBP
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
globenewswire.com
CRBP
Exosome Research Market Analysis, Opportunity Forecasts Report 2026-2035
globenewswire.com
CRBP
BTAI
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP